Frontlight ResearchEarly access
Trial site
ThedaCare Cancer Care - Berlin
- 18running trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Colorectal cancer4 trials
- Childhood cancers3 trials
- Ovarian cancer3 trials
- Acute lymphoblastic leukaemia2 trials
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Endometrial cancer1 trial
- and 8 more
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Active, not recruiting9 trials
- Recruiting9 trials
- Lead sponsor
- National Cancer Institute (NCI)7 trials
- Alliance for Clinical Trials in Oncology4 trials
- ECOG-ACRIN Cancer Research Group2 trials
- NRG Oncology2 trials
- PrECOG, LLC.1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Colorectal cancer3 recruiting
- Ovarian cancer3 recruiting
- Childhood cancers2 recruiting
- Melanoma2 recruiting
- Metastatic breast cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Multiple myeloma1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026